Reperfusion therapy stands as a pivotal medical intervention crafted to reinstate the circulation of blood to tissues or organs following a period of restricted or obstructed flow, typically observed in conditions like heart attacks or strokes. The fundamental objective of reperfusion is to rescue imperiled tissue by rapidly restoring the supply of oxygen and nutrients. This therapeutic strategy finds prominent application in the context of myocardial infarctions, where timely intervention holds the promise of minimizing cardiac damage and enhancing overall patient outcomes. Diverse reperfusion approaches are available, ranging from the administration of clot-dissolving medications to the utilization of catheter-based procedures aimed at reopening obstructed vessels. Despite its potential to save lives, the efficacy of reperfusion therapy is contingent upon swift diagnosis and timely implementation, underscoring its indispensable role in the sphere of cardiovascular and neurological care.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt